Invention Grant
- Patent Title: Pyrrolopyridine inhibitors of kinases
- Patent Title (中): 吡咯并吡啶类激酶抑制剂
-
Application No.: US14444540Application Date: 2014-07-28
-
Publication No.: US09181246B2Publication Date: 2015-11-10
- Inventor: Thomas D. Penning , Keith W. Woods , Chunqiu Lai , Alan S. Florjancic , Yunsong Tong
- Applicant: AbbVie Inc.
- Applicant Address: US IL North Chicago
- Assignee: AbbVie Inc.
- Current Assignee: AbbVie Inc.
- Current Assignee Address: US IL North Chicago
- Agent Changxia Sun
- Main IPC: A61K31/395
- IPC: A61K31/395 ; A61K31/505 ; A61K31/535 ; A61K31/44 ; C07D239/02 ; C07D401/04 ; C07D279/10 ; C07D471/04
Abstract:
The present invention relates to compounds of formula (I) or pharmaceutical acceptable salts, wherein R1a, R1b, R1c, X, and Y are defined in the description. The present invention relates also to compositions containing said compounds which are useful for inhibiting kinases such as Cdc7 and methods of treating diseases such as cancer.
Public/Granted literature
- US20140357616A1 PYRROLOPYRIDINE INHIBITORS OF KINASES Public/Granted day:2014-12-04
Information query
